Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77729103 | 7772910 | 3 | F | 20101101 | 20160823 | 20110125 | 20160914 | EXP | US-ROCHE-754175 | ROCHE | 59.75 | YR | F | Y | 66.00000 | KG | 20160914 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77729103 | 7772910 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | OVER 30-90 MINUTES ON DAYS 01 AND 15, DOSE: 1446 MG, COURSE 1 | 125085 | 10 | MG/KG | ||||||||
| 77729103 | 7772910 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | OVER 30-90 MINUTES ON DAYS 01 AND 15, DOSE: 666 MG, COURSE 2 | 125085 | 10 | MG/KG | ||||||||
| 77729103 | 7772910 | 3 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | ON DAYS 1, 8, 15 AND 22, COURSE 1 | 0 | 100 | MG | ||||||||
| 77729103 | 7772910 | 4 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | ON DAYS 1, 8, 15 AND 22, COURSE 2 | 0 | 25 | MG | ||||||||
| 77729103 | 7772910 | 5 | SS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | 0 | |||||||||||
| 77729103 | 7772910 | 6 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0 | ||||||||||||
| 77729103 | 7772910 | 7 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 77729103 | 7772910 | 8 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 77729103 | 7772910 | 1 | Endometrial cancer |
| 77729103 | 7772910 | 3 | Endometrial cancer |
| 77729103 | 7772910 | 5 | Vena cava thrombosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 77729103 | 7772910 | HO |
| 77729103 | 7772910 | OT |
| 77729103 | 7772910 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 77729103 | 7772910 | Aorto-duodenal fistula | |
| 77729103 | 7772910 | Death | |
| 77729103 | 7772910 | Duodenal perforation | |
| 77729103 | 7772910 | Embolism | |
| 77729103 | 7772910 | Gastric haemorrhage | |
| 77729103 | 7772910 | Lower gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |